These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20861111)

  • 1. Gastro-oesophageal reflux. Issues in clinical practice.
    Mir NA
    BMJ; 2010 Sep; 341():c5158. PubMed ID: 20861111
    [No Abstract]   [Full Text] [Related]  

  • 2. Gaviscon for gastro-oesophageal reflux in infants: a poorly effective treatment?
    Cresi F; Savino F; Marinaccio C; Silvestro L
    Arch Dis Child; 2006 Jan; 91(1):93. PubMed ID: 16371388
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.
    Corvaglia L; Aceti A; Mariani E; De Giorgi M; Capretti MG; Faldella G
    Aliment Pharmacol Ther; 2011 Feb; 33(4):466-70. PubMed ID: 21158879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between cisapride and Gaviscon with Carobel in the treatment of gastro-oesophageal reflux in infancy.
    Greally P; Hampton FJ; MacFadyen UM; Simpson H
    Ir Med J; 1992; 85(4 Suppl):14. PubMed ID: 1490841
    [No Abstract]   [Full Text] [Related]  

  • 5. Algicon in the management of gastro-oesophageal reflux.
    Lambert JR; Korman MG; Nicholson L
    Br J Clin Pract Suppl; 1989 Feb; 66():56-8; discussion 61-4. PubMed ID: 2556177
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux.
    Ward AE
    Br J Clin Pract Suppl; 1989 Feb; 66():52-5; discussion 61-4. PubMed ID: 2556176
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of gastro-esophageal reflux using a potable gaviscon suspension].
    Guerre J; Neuman M; Bouchet J
    Med Chir Dig; 1982; 11(4):289-95. PubMed ID: 6287126
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH.
    Del Buono R; Wenzl TG; Ball G; Keady S; Thomson M
    Arch Dis Child; 2005 May; 90(5):460-3. PubMed ID: 15851425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alginate-raft preparations in the treatment of acid reflux and heartburn (literature review)].
    Mandel KG; Deggi BP; Brodi DA; Jeykobi GI
    Eksp Klin Gastroenterol; 2008; (4):64-77. PubMed ID: 19145905
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study on the raft chemical properties of various alginate antacid raft-forming products.
    Dettmar PW; Gil-Gonzalez D; Fisher J; Flint L; Rainforth D; Moreno-Herrera A; Potts M
    Drug Dev Ind Pharm; 2018 Jan; 44(1):30-39. PubMed ID: 28836872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with sodium alginate of gastroesophageal reflux disease in childhood: efficacy and tolerance assessment].
    Maestri L
    Pediatr Med Chir; 2001; 23(3-4):187-9. PubMed ID: 11723856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
    Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
    Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gastroesophageal reflux disease during pregnancy].
    Elokhina TB; Tiutiunnik VL
    Eksp Klin Gastroenterol; 2009; (3):93-7. PubMed ID: 19928006
    [No Abstract]   [Full Text] [Related]  

  • 14. The suppression of gastro-oesophageal reflux by alginates.
    Dettmar PW; Hampson FC; Taubel J; Lorch U; Johnstone LM; Sykes J; Berry PJ
    Int J Clin Pract; 2007 Oct; 61(10):1654-62. PubMed ID: 17681004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estimation of efficiency of alginate-raft barrier in treatment of gastroesophageal reflux disease].
    Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
    Eksp Klin Gastroenterol; 2008; (6):77-81. PubMed ID: 19334430
    [No Abstract]   [Full Text] [Related]  

  • 16. [Esophageal reflux and peptic ulcer. An exclusive advanced education service of the Gastro-Liga for family physicians].
    Fortschr Med; 1998 Dec; 116(34):35-8. PubMed ID: 10024760
    [No Abstract]   [Full Text] [Related]  

  • 17. [Can acid pocket-targeting alginate-antacid (Gaviscon Double Action) relieve upper gastrointestinal symptoms in gastro-oesophageal reflux disease?].
    Kim SE; Park MI
    Korean J Gastroenterol; 2014 Jun; 63(6):386-8. PubMed ID: 25097964
    [No Abstract]   [Full Text] [Related]  

  • 18. [Failure of amiodarone in supraventricular tachycardia in an infant: drug interaction with Gaviscon(®)?].
    Chantepie A; Lefort B; Méot M; Jandali JC; Soulé N; Chantreuil J; Vaillant MC; Tisseron B
    Arch Pediatr; 2014 Jun; 21(6):663-4. PubMed ID: 24768351
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gaviscon in reflux symptoms. Results of a drug monitoring study].
    Hutt HJ; Tauber O; Flach D
    Fortschr Med; 1990 Oct; 108(31):598-600. PubMed ID: 2258131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing childhood gastro-oesophageal reflux.
    Drug Ther Bull; 1997 Oct; 35(10):77-80. PubMed ID: 9489057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.